{"title":"贵阳地区9 334例地中海贫血基因筛查结果分析","authors":"Chun-Huan Zhou, Wen-Bing Zou, Zheng-Yuan Cao","doi":"10.19746/j.cnki.issn.1009-2137.2025.02.026","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To investigate the common genotypes and distribution characteristics of thalassemia in Guiyang region, and preliminarily analyze the rare mutations of globin genes in this area.</p><p><strong>Methods: </strong>A total of 9 334 individuals who came to our hospital for thalassemia screening from June 2016 to February 2023 were included in this study. They were examined for common thalassemia mutations using PCR-based flow-through hybridization technology. Meanwhile, rare and unknown mutations were detected by Sanger sequencing.</p><p><strong>Results: </strong>Among the 9 334 cases, 895 positive cases of common thalassemia were detected, with a positive rate of 9.59%. Among the positive samples, 565 cases (63.13%) were confirmed to be α thalassemia, of which the most common genotypes were αα/-α<sup>3.7</sup> (46.37%), followed by αα/--<sup><i>SEA</i></sup>(26.55%) and αα/-α<sup>4.2</sup>(10.62%); 310 cases (34.64%) were diagnosed as β thalassemia, with β<sup><i>CD17</i></sup>/β<sup><i>N</i></sup> (39.35%) being the most frequent genotype, followed by β<sup><i>CD41-42</i></sup> /β<sup><i>N</i></sup> (31.29%) and β <i><sup>IVS-II-654</sup></i>/ β<sup><i>N</i></sup> (12.90%). There were 20 cases (2.23%) of αβ complex thalassemia, mainly being αα/-α<sup>3.7</sup> combined with β<sup><i>CD17</i></sup> /β<sup><i>N</i></sup> . Additionally, 8 cases of rare globin gene mutations were found by Sanger sequencing, including 7 mutation types. Among them, <i>HBB: c. -137C> T (-87 C>T)</i> was reported for the first time in Guizhou; <i>HBA1 : c.*29C>T</i> and <i>HBB : c. 93-50C>T (IVS I-81C>T)</i> were new mutations that had not been recorded in either the HbVar or IthaGenes database.</p><p><strong>Conclusion: </strong>Guiyang region has a high incidence of thalassemia mutations, and these mutations are diverse and complex. Analyzing gene mutation types of thalassemia in this area can contribute to the prevention of the birth of children with severe thalassemia.</p>","PeriodicalId":35777,"journal":{"name":"中国实验血液学杂志","volume":"33 2","pages":"486-490"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Analysis of the Results of Thalassemia Gene Screening in 9 334 Cases in Guiyang Region].\",\"authors\":\"Chun-Huan Zhou, Wen-Bing Zou, Zheng-Yuan Cao\",\"doi\":\"10.19746/j.cnki.issn.1009-2137.2025.02.026\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To investigate the common genotypes and distribution characteristics of thalassemia in Guiyang region, and preliminarily analyze the rare mutations of globin genes in this area.</p><p><strong>Methods: </strong>A total of 9 334 individuals who came to our hospital for thalassemia screening from June 2016 to February 2023 were included in this study. They were examined for common thalassemia mutations using PCR-based flow-through hybridization technology. Meanwhile, rare and unknown mutations were detected by Sanger sequencing.</p><p><strong>Results: </strong>Among the 9 334 cases, 895 positive cases of common thalassemia were detected, with a positive rate of 9.59%. Among the positive samples, 565 cases (63.13%) were confirmed to be α thalassemia, of which the most common genotypes were αα/-α<sup>3.7</sup> (46.37%), followed by αα/--<sup><i>SEA</i></sup>(26.55%) and αα/-α<sup>4.2</sup>(10.62%); 310 cases (34.64%) were diagnosed as β thalassemia, with β<sup><i>CD17</i></sup>/β<sup><i>N</i></sup> (39.35%) being the most frequent genotype, followed by β<sup><i>CD41-42</i></sup> /β<sup><i>N</i></sup> (31.29%) and β <i><sup>IVS-II-654</sup></i>/ β<sup><i>N</i></sup> (12.90%). There were 20 cases (2.23%) of αβ complex thalassemia, mainly being αα/-α<sup>3.7</sup> combined with β<sup><i>CD17</i></sup> /β<sup><i>N</i></sup> . Additionally, 8 cases of rare globin gene mutations were found by Sanger sequencing, including 7 mutation types. Among them, <i>HBB: c. -137C> T (-87 C>T)</i> was reported for the first time in Guizhou; <i>HBA1 : c.*29C>T</i> and <i>HBB : c. 93-50C>T (IVS I-81C>T)</i> were new mutations that had not been recorded in either the HbVar or IthaGenes database.</p><p><strong>Conclusion: </strong>Guiyang region has a high incidence of thalassemia mutations, and these mutations are diverse and complex. Analyzing gene mutation types of thalassemia in this area can contribute to the prevention of the birth of children with severe thalassemia.</p>\",\"PeriodicalId\":35777,\"journal\":{\"name\":\"中国实验血液学杂志\",\"volume\":\"33 2\",\"pages\":\"486-490\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中国实验血液学杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.19746/j.cnki.issn.1009-2137.2025.02.026\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国实验血液学杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.19746/j.cnki.issn.1009-2137.2025.02.026","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
目的:了解贵阳地区地中海贫血的常见基因型及分布特点,初步分析该地区罕见的珠蛋白基因突变。方法:选取2016年6月至2023年2月来我院进行地中海贫血筛查的9 334例患者作为研究对象。他们使用基于pcr的流式杂交技术检测常见的地中海贫血突变。同时,Sanger测序检测到罕见和未知的突变。结果:9 334例中检出普通地中海贫血阳性895例,阳性率为9.59%。阳性样本中,确诊α地中海贫血565例(63.13%),其中最常见的基因型为αα/-α3.7(46.37%),其次为αα/—SEA(26.55%)和αα/-α4.2(10.62%);β地中海贫血310例(34.64%),以β cd17 /β n(39.35%)基因型最为常见,其次为β cd41 -42 /β n(31.29%)和β IVS-II-654/ β n(12.90%)。αβ复合型地中海贫血20例(2.23%),以αα/-α3.7合并βCD17 /βN为主。Sanger测序发现8例罕见珠蛋白基因突变,包括7种突变类型。其中,HBB: c. -137C> T (-87 c >T)为贵州首次报道;HBA1: c.*29C>T和HBB: c. 93-50C>T (IVS I-81C>T)是HbVar或IthaGenes数据库中未记录的新突变。结论:贵阳地区地中海贫血突变高发,且突变多样、复杂。分析该地区地中海贫血的基因突变类型有助于预防出生患有严重地中海贫血的儿童。
[Analysis of the Results of Thalassemia Gene Screening in 9 334 Cases in Guiyang Region].
Objective: To investigate the common genotypes and distribution characteristics of thalassemia in Guiyang region, and preliminarily analyze the rare mutations of globin genes in this area.
Methods: A total of 9 334 individuals who came to our hospital for thalassemia screening from June 2016 to February 2023 were included in this study. They were examined for common thalassemia mutations using PCR-based flow-through hybridization technology. Meanwhile, rare and unknown mutations were detected by Sanger sequencing.
Results: Among the 9 334 cases, 895 positive cases of common thalassemia were detected, with a positive rate of 9.59%. Among the positive samples, 565 cases (63.13%) were confirmed to be α thalassemia, of which the most common genotypes were αα/-α3.7 (46.37%), followed by αα/--SEA(26.55%) and αα/-α4.2(10.62%); 310 cases (34.64%) were diagnosed as β thalassemia, with βCD17/βN (39.35%) being the most frequent genotype, followed by βCD41-42 /βN (31.29%) and β IVS-II-654/ βN (12.90%). There were 20 cases (2.23%) of αβ complex thalassemia, mainly being αα/-α3.7 combined with βCD17 /βN . Additionally, 8 cases of rare globin gene mutations were found by Sanger sequencing, including 7 mutation types. Among them, HBB: c. -137C> T (-87 C>T) was reported for the first time in Guizhou; HBA1 : c.*29C>T and HBB : c. 93-50C>T (IVS I-81C>T) were new mutations that had not been recorded in either the HbVar or IthaGenes database.
Conclusion: Guiyang region has a high incidence of thalassemia mutations, and these mutations are diverse and complex. Analyzing gene mutation types of thalassemia in this area can contribute to the prevention of the birth of children with severe thalassemia.